COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

Policy Brief

COVID-19 Vaccines: Ensuring Regulatory and Scientific Integrity During the Approval Process

Published date

October 22, 2020

Duke-Margolis Affiliated Authors

William K. Bleser - Margolis headhot

William K. Bleser, PhD, MSPH

Assistant Research Director, Health Care Transformation for Population Health, Social Needs, and Health Equity
Senior Team Member
Anti-Racism and Equity Committee Member

morgan romine

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty